Form 4: HREGEN CEO Junli He Acquires 2,299 Shares in Open Market Transaction

HREGEN CEO Junli He acquired 2,299 shares of common stock at a weighted average price of $2.87 per share.

Summary

• Junli He, the CEO of Harvard Apparatus Regenerative Technology, Inc. (HREGEN), purchased 2,299 shares of the company's common stock.
• The shares were acquired through multiple transactions between December 24, 2024 and December 30, 2024.
• The weighted average price paid per share was $2.87.
• Following the transaction, Mr. He directly owns 262,000 shares of HREGEN common stock.

Sentiment

Score: 6

Explanation: The document reflects a routine insider purchase, which is generally neutral to slightly positive. It indicates confidence from the CEO but is not a major event.

Positives

• The CEO's purchase of shares could be seen as a positive sign of confidence in the company's future.

Industry Context

Insider trading activity is closely monitored by investors as it can provide insights into management's view of the company's prospects.

Comparison to Industry Standards

• It is common for executives to purchase shares in their own companies, and this transaction is within the normal range of such activities.
• The purchase is relatively small compared to the total number of shares outstanding, and is not unusual for a CEO.

Stakeholder Impact

• The purchase may have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

HREGEN, Junli He, insider trading, stock purchase, CEO, common stock, SEC Form 4